Stock Scorecard

Stock Summary for Rocket Pharmaceuticals Inc (RCKT) - $3.64 as of 8/22/2025 8:33:14 PM EST

Total Score

10 out of 30

Safety Score

33 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RCKT

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RCKT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RCKT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for RCKT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for RCKT (33 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for RCKT

RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study 8/21/2025 3:13:00 PM
Coty, Bilibili, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Bilibili ( NASDAQ:BILI ) , Coty ( NYSE:COTY ) 8/21/2025 12:19:00 PM
Why Nordson Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Aegon ( NYSE:AEG ) , Aethlon Medical ( NASDAQ:AEMD ) 8/21/2025 9:23:00 AM
TJX Posts Better-Than-Expected Earnings, Joins Rocket Pharmaceuticals, Guess? And Other Big Stocks Moving Higher On Wednesday - Almonty Indus ( NASDAQ:ALM ) , Aspen Insurance Hldgs ( NYSE:AHL ) 8/20/2025 1:58:00 PM
Why Is Rocket Pharmaceuticals Stock Rallying Today - Rocket Pharmaceuticals ( NASDAQ:RCKT ) 8/20/2025 1:31:00 PM
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Color Star Tech ( NASDAQ:ADD ) , Aspen Insurance Hldgs ( NYSE:AHL ) 8/20/2025 11:24:00 AM
Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT - Rocket Pharmaceuticals ( NASDAQ:RCKT ) 8/11/2025 8:25:00 PM
DEADLINE ALERT for RCKT, TEM, and DDD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - 3D Sys ( NYSE:DDD ) , Rocket Pharmaceuticals ( NASDAQ:RCKT ) 8/11/2025 2:15:00 PM
RCKT DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action - RCKT - Rocket Pharmaceuticals ( NASDAQ:RCKT ) 8/10/2025 3:38:00 PM
RCKT DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in... 8/10/2025 12:22:00 AM

Financial Details for RCKT

Company Overview
Ticker RCKT
Company Name Rocket Pharmaceuticals Inc
Country USA
Description Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2025
Next Earnings Date 11/5/2025

Stock Price History
Last Day Price 3.64
Price 4 Years Ago 21.83
Last Day Price Updated 8/22/2025 8:33:14 PM EST
Last Day Volume 7,368,255
Average Daily Volume 4,926,467
52-Week High 22.01
52-Week Low 2.19
Last Price to 52 Week Low 66.21%

Valuation Measures
Trailing PE N/A
Industry PE 40.56
Sector PE 58.53
5-Year Average PE -6.19
Free Cash Flow Ratio 12.13
Industry Free Cash Flow Ratio 15.42
Sector Free Cash Flow Ratio 30.30
Current Ratio Most Recent Quarter 6.39
Total Cash Per Share 0.30
Book Value Per Share Most Recent Quarter 3.28
Price to Book Ratio 1.14
Industry Price to Book Ratio 29.05
Sector Price to Book Ratio 26.66
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 25.49
Sector Price to Sales Ratio Twelve Trailing Months 13.25
Analyst Buy Ratings 7
Analyst Strong Buy Ratings 1

Share Statistics
Total Shares Outstanding 107,904,000
Market Capitalization 392,770,560
Institutional Ownership 91.39%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -5.35%
Reported EPS 12 Trailing Months -2.51
Reported EPS Past Year -1.18
Reported EPS Prior Year -2.73
Net Income Twelve Trailing Months -257,299,000
Net Income Past Year -258,746,000
Net Income Prior Year -245,595,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet
Total Cash Most Recent Quarter 32,819,000
Total Cash Past Year 163,635,000
Total Cash Prior Year 55,904,000
Net Cash Position Most Recent Quarter 32,819,000
Net Cash Position Past Year 123,694,000
Long Term Debt Past Year 39,941,000
Long Term Debt Prior Year 39,941,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 0.92
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 463,234,000
Total Stockholder Equity Prior Year 492,574,000
Total Stockholder Equity Most Recent Quarter 354,211,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months -206,110,000
Free Cash Flow Per Share Twelve Trailing Months -1.91
Free Cash Flow Past Year -215,586,000
Free Cash Flow Prior Year -211,388,000

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.07
MACD Signal -0.01
20-Day Bollinger Lower Band 0.56
20-Day Bollinger Middle Band 4.25
20-Day Bollinger Upper Band 7.94
Beta 0.65
RSI 66.92
50-Day SMA 9.71
150-Day SMA 17.47
200-Day SMA 17.47

System
Modified 8/21/2025 9:18:20 AM EST